+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cushings Disease Drug"

Cushing Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
From
From
Cushing Syndrome Market 2025-2029 - Product Thumbnail Image

Cushing Syndrome Market 2025-2029

  • Report
  • March 2025
  • 194 Pages
  • Global
From
Cushing's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cushing's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Endogenous Cushing's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Endogenous Cushing's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Endogenous Cushing's Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Endogenous Cushing's Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Cushing's Disease is a rare endocrine disorder caused by an excess of cortisol in the body. Treatment for Cushing's Disease typically involves a combination of medications, surgery, and radiation therapy. Endocrine and Metabolic Disorders Drugs are used to treat Cushing's Disease, as well as other endocrine and metabolic disorders. These drugs are used to reduce cortisol levels, regulate hormones, and reduce inflammation. Common drugs used to treat Cushing's Disease include corticosteroids, somatostatin analogs, and dopamine agonists. The Cushing's Disease Drug market is a niche market, with a limited number of drugs available. However, the market is expected to grow in the coming years due to the increasing prevalence of Cushing's Disease. Companies in the Cushing's Disease Drug market include Novartis, Pfizer, Merck, and AbbVie. Show Less Read more